Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 355

1.

The photoreactive free radical in eumelanin.

Mostert AB, Rienecker SB, Noble C, Hanson GR, Meredith P.

Sci Adv. 2018 Mar 28;4(3):eaaq1293. doi: 10.1126/sciadv.aaq1293. eCollection 2018 Mar.

2.

Evaluation of low-frequency operational limit of proposed ITER low-field-side reflectometer waveguide run including miter bends.

Wang G, Peebles WA, Doyle EJ, Crocker NA, Wannberg C, Lau C, Hanson GR, Doane JL.

Rev Sci Instrum. 2017 Oct;88(10):103508. doi: 10.1063/1.4995662.

PMID:
29092526
3.

Tolyporphin Macrocycles from the Cyanobacterium Tolypothrix nodosa Selectively Bind Copper and Silver and Reverse Multidrug Resistance.

Prinsep MR, Appleton TG, Hanson GR, Lane I, Smith CD, Puddick J, Fairlie DP.

Inorg Chem. 2017 May 15;56(10):5577-5585. doi: 10.1021/acs.inorgchem.6b03000. Epub 2017 Feb 27.

PMID:
28240882
4.

Dinuclear ZnII and mixed CuII-ZnII complexes of artificial patellamides as phosphatase models.

Comba P, Eisenschmidt A, Gahan LR, Hanson GR, Mehrkens N, Westphal M.

Dalton Trans. 2016 Dec 21;45(47):18931-18945. Epub 2016 Nov 14.

PMID:
27841434
5.

ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse.

Barak LS, Bai Y, Peterson S, Evron T, Urs NM, Peddibhotla S, Hedrick MP, Hershberger P, Maloney PR, Chung TD, Rodriguiz RM, Wetsel WC, Thomas JB, Hanson GR, Pinkerton AB, Caron MG.

ACS Chem Biol. 2016 Jul 15;11(7):1880-90. doi: 10.1021/acschembio.6b00291. Epub 2016 May 5.

6.

Effects of mutations in active site heme ligands on the spectroscopic and catalytic properties of SoxAX cytochromes.

Kilmartin JR, Bernhardt PV, Dhouib R, Hanson GR, Riley MJ, Kappler U.

J Inorg Biochem. 2016 Sep;162:309-318. doi: 10.1016/j.jinorgbio.2016.04.015. Epub 2016 Apr 15.

PMID:
27112898
7.

Sex differences in neurotensin and substance P following nicotine self-administration in rats.

Pittenger ST, Swalve N, Chou S, Smith MD, Hoonakker AJ, Pudiak CM, Fleckenstein AE, Hanson GR, Bevins RA.

Synapse. 2016 Aug;70(8):336-46. doi: 10.1002/syn.21907. Epub 2016 May 4.

8.

Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.

Baladi MG, Nielsen SM, McIntosh JM, Hanson GR, Fleckenstein AE.

Behav Pharmacol. 2016 Aug;27(5):422-30. doi: 10.1097/FBP.0000000000000215.

9.

An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity.

Fricks-Gleason AN, German CL, Hoonakker AJ, Friend DM, Ganesh KK, Carver AS, Hanson GR, Fleckenstein AE, Keefe KA.

Synapse. 2016 Apr;70(4):139-46. doi: 10.1002/syn.21891. Epub 2016 Feb 15.

PMID:
26799527
10.

Structural basis of interprotein electron transfer in bacterial sulfite oxidation.

McGrath AP, Laming EL, Casas Garcia GP, Kvansakul M, Guss JM, Trewhella J, Calmes B, Bernhardt PV, Hanson GR, Kappler U, Maher MJ.

Elife. 2015 Dec 19;4:e09066. doi: 10.7554/eLife.09066.

11.

Heavy Water as a Probe of the Free Radical Nature and Electrical Conductivity of Melanin.

Rienecker SB, Mostert AB, Schenk G, Hanson GR, Meredith P.

J Phys Chem B. 2015 Dec 3;119(48):14994-5000. doi: 10.1021/acs.jpcb.5b08970. Epub 2015 Nov 18.

PMID:
26580677
12.

Selective Coordination of Gallium(III), Zinc(II), and Copper(II) by an Asymmetric Dinucleating Ligand: A Model for Metallophosphatases.

Bosch S, Comba P, Gahan LR, Hanson GR, Noble C, Schenk G, Wadepohl H.

Chemistry. 2015 Dec 7;21(50):18269-79. doi: 10.1002/chem.201503348. Epub 2015 Nov 18.

PMID:
26577705
13.

Identification of a neuropeptide precursor protein that gives rise to a "cocktail" of peptides that bind Cu(II) and generate metal-linked dimers.

Jones CE, Zandawala M, Semmens DC, Anderson S, Hanson GR, Janies DA, Elphick MR.

Biochim Biophys Acta. 2016 Jan;1860(1 Pt A):57-66. doi: 10.1016/j.bbagen.2015.10.008. Epub 2015 Oct 22.

PMID:
26475641
14.

Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE.

Pharmacol Rev. 2015 Oct;67(4):1005-24. doi: 10.1124/pr.114.010397. Review.

15.

Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.

Vieira-Brock PL, McFadden LM, Nielsen SM, Ellis JD, Walters ET, Stout KA, McIntosh JM, Wilkins DG, Hanson GR, Fleckenstein AE.

J Pharmacol Exp Ther. 2015 Dec;355(3):463-72. doi: 10.1124/jpet.114.221945. Epub 2015 Sep 21.

16.

An Approach to More Accurate Model Systems for Purple Acid Phosphatases (PAPs).

Bernhardt PV, Bosch S, Comba P, Gahan LR, Hanson GR, Mereacre V, Noble CJ, Powell AK, Schenk G, Wadepohl H.

Inorg Chem. 2015 Aug 3;54(15):7249-63. doi: 10.1021/acs.inorgchem.5b00628. Epub 2015 Jul 21.

PMID:
26196255
17.

Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.

Vieira-Brock PL, McFadden LM, Nielsen SM, Smith MD, Hanson GR, Fleckenstein AE.

Int J Neuropsychopharmacol. 2015 Jul 11;18(12). pii: pyv073. doi: 10.1093/ijnp/pyv073.

18.

Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.

Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR.

Synapse. 2015 Aug;69(8):396-404. doi: 10.1002/syn.21829. Epub 2015 Jun 11.

19.

Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.

McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE.

Neuropharmacology. 2015 Jun;93:146-54. doi: 10.1016/j.neuropharm.2015.01.013. Epub 2015 Jan 31.

20.

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment.

Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR.

Drug Alcohol Depend. 2015 Jan 1;146:30-8. doi: 10.1016/j.drugalcdep.2014.10.027. Epub 2014 Nov 16.

21.

Using X-mode L, R and O-mode reflectometry cutoffs to measure scrape-off-layer density profiles for upgraded ORNL reflectometer on NSTX-U.

Lau C, Wilgen JB, Caughman JB, Hanson GR, Hosea J, Perkins R, Ryan PM, Taylor G.

Rev Sci Instrum. 2014 Nov;85(11):11D815. doi: 10.1063/1.4889739.

PMID:
25430228
22.

Insights into the electronic structure of Cu(II) bound to an imidazole analogue of westiellamide.

Comba P, Dovalil N, Hanson GR, Harmer JR, Noble CJ, Riley MJ, Seibold B.

Inorg Chem. 2014 Dec 1;53(23):12323-36. doi: 10.1021/ic5014413. Epub 2014 Nov 13.

PMID:
25393875
23.

Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats.

Baladi MG, Nielsen SM, Umpierre A, Hanson GR, Fleckenstein AE.

Behav Pharmacol. 2014 Dec;25(8):758-65. doi: 10.1097/FBP.0000000000000094.

24.

Control of excitation and quenching in multi-colour electrogenerated chemiluminescence systems through choice of co-reactant.

Barbante GJ, Kebede N, Hindson CM, Doeven EH, Zammit EM, Hanson GR, Hogan CF, Francis PS.

Chemistry. 2014 Oct 20;20(43):14026-31. doi: 10.1002/chem.201403767. Epub 2014 Sep 9.

PMID:
25204830
25.

Mephedrone alters basal ganglia and limbic dynorphin systems.

German CL, Alburges ME, Hoonakker AJ, Fleckenstein AE, Hanson GR.

Synapse. 2014 Dec;68(12):634-640. doi: 10.1002/syn.21778. Epub 2014 Sep 8.

26.

Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.

Baladi MG, Newman AH, Nielsen SM, Hanson GR, Fleckenstein AE.

Eur J Pharmacol. 2014 Jun 5;732:105-10. doi: 10.1016/j.ejphar.2014.03.023. Epub 2014 Mar 28.

27.

Mephedrone alters basal ganglia and limbic neurotensin systems.

German CL, Hoonakker AH, Fleckenstein AE, Hanson GR.

J Neurochem. 2014 Aug;130(3):402-7. doi: 10.1111/jnc.12727. Epub 2014 Apr 19.

28.

Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.

McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1315-20. doi: 10.1017/S1461145714000327. Epub 2014 Mar 20.

29.

Electronic structure of the oxygen evolving complex in photosystem II, as revealed by 55Mn Davies ENDOR studies at 2.5 K.

Jin L, Smith P, Noble CJ, Stranger R, Hanson GR, Pace RJ.

Phys Chem Chem Phys. 2014 May 7;16(17):7799-812. doi: 10.1039/c3cp55189j.

PMID:
24643307
30.

Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.

Peddibhotla S, Hedrick MP, Hershberger P, Maloney PR, Li Y, Milewski M, Gosalia P, Gray W, Mehta A, Sugarman E, Hood B, Suyama E, Nguyen K, Heynen-Genel S, Vasile S, Salaniwal S, Stonich D, Su Y, Mangravita-Novo A, Vicchiarelli M, Roth GP, Smith LH, Chung TD, Hanson GR, Thomas JB, Caron MG, Barak LS, Pinkerton AB.

ACS Med Chem Lett. 2013 Jul 20;4(9):846-851.

31.

Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.

Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR.

Psychopharmacology (Berl). 2014 Aug;231(15):2933-40. doi: 10.1007/s00213-014-3468-7. Epub 2014 Feb 13.

32.

Carbonic anhydrase activity of dinuclear Cu(II) complexes with patellamide model ligands.

Comba P, Gahan LR, Hanson GR, Maeder M, Westphal M.

Dalton Trans. 2014 Feb 28;43(8):3144-52. doi: 10.1039/c3dt53135j.

PMID:
24326405
33.

Cyclic peptide marine metabolites and CuII.

Comba P, Dovalil N, Gahan LR, Hanson GR, Westphal M.

Dalton Trans. 2014 Feb 7;43(5):1935-56. doi: 10.1039/c3dt52664j. Review.

PMID:
24202205
34.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

German CL, Fleckenstein AE, Hanson GR.

Life Sci. 2014 Feb 27;97(1):2-8. doi: 10.1016/j.lfs.2013.07.023. Epub 2013 Aug 2. Review.

35.

The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations.

McFadden LM, Hanson GR, Fleckenstein AE.

Synapse. 2013 Dec;67(12):875-81. doi: 10.1002/syn.21696. Epub 2013 Jul 27.

36.

The tachykinin peptide neurokinin B binds copper forming an unusual [CuII(NKB)2] complex and inhibits copper uptake into 1321N1 astrocytoma cells.

Russino D, McDonald E, Hejazi L, Hanson GR, Jones CE.

ACS Chem Neurosci. 2013 Oct 16;4(10):1371-81. doi: 10.1021/cn4000988. Epub 2013 Aug 7.

37.

Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.

Hanson GR, Hoonakker AJ, Robson CM, McFadden LM, Frankel PS, Alburges ME.

J Pharmacol Exp Ther. 2013 Aug;346(2):173-81. doi: 10.1124/jpet.113.205310. Epub 2013 May 17.

38.

Autocatalytic chemiluminescence sheds new light on the classic permanganate-oxalate reaction.

Hindson CM, Smith ZM, Barnett NW, Hanson GR, Lim KF, Francis PS.

J Phys Chem A. 2013 May 16;117(19):3918-24. doi: 10.1021/jp312603m. Epub 2013 May 3.

PMID:
23676000
39.

Hydration-controlled X-band EPR spectroscopy: a tool for unravelling the complexities of the solid-state free radical in eumelanin.

Mostert AB, Hanson GR, Sarna T, Gentle IR, Powell BJ, Meredith P.

J Phys Chem B. 2013 May 2;117(17):4965-72. doi: 10.1021/jp401615e. Epub 2013 Apr 19.

PMID:
23600769
40.

The trivalent copper complex of a conjugated bis-dithiocarbazate Schiff base: stabilization of Cu in three different oxidation states.

Akbar Ali M, Bernhardt PV, Brax MA, England J, Farlow AJ, Hanson GR, Yeng LL, Mirza AH, Wieghardt K.

Inorg Chem. 2013 Feb 4;52(3):1650-7. doi: 10.1021/ic302596h. Epub 2013 Jan 16.

PMID:
23324063
41.

Spectroscopic characterization of the active Fe(III)Fe(III) and Fe(III)Fe(II) forms of a purple acid phosphatase model system.

Comba P, Gahan LR, Mereacre V, Hanson GR, Powell AK, Schenk G, Zajaczkowski-Fischer M.

Inorg Chem. 2012 Nov 19;51(22):12195-209. doi: 10.1021/ic301347t. Epub 2012 Oct 30.

PMID:
23110717
42.

Patient-empowerment interactive technologies.

Bruggers CS, Altizer RA, Kessler RR, Caldwell CB, Coppersmith K, Warner L, Davies B, Paterson W, Wilcken J, D'Ambrosio TA, German ML, Hanson GR, Gershan LA, Korenberg JR, Bulaj G.

Sci Transl Med. 2012 Sep 19;4(152):152ps16.

PMID:
22993292
43.

Phosphatase reactivity of a dicopper(II) complex of a patellamide derivative--possible biological functions of cyclic pseudopeptides.

Comba P, Gahan LR, Hanson GR, Westphal M.

Chem Commun (Camb). 2012 Sep 28;48(75):9364-6. doi: 10.1039/c2cc34836e. Epub 2012 Aug 15.

PMID:
22892984
44.

Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.

German CL, Hanson GR, Fleckenstein AE.

J Neurochem. 2012 Oct;123(2):288-97. doi: 10.1111/j.1471-4159.2012.07875.x. Epub 2012 Aug 23.

45.

Formation of an unusual four-membered nitrogen ring (tetrazetidine) radical cation.

Camp D, Campitelli M, Hanson GR, Jenkins ID.

J Am Chem Soc. 2012 Oct 3;134(39):16188-96. doi: 10.1021/ja303019y. Epub 2012 Jul 10.

PMID:
22708894
46.

Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

McFadden LM, Hunt MM, Vieira-Brock PL, Muehle J, Nielsen SM, Allen SC, Hanson GR, Fleckenstein AE.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):87-94. doi: 10.1016/j.drugalcdep.2012.04.020. Epub 2012 May 28.

47.

Role of semiconductivity and ion transport in the electrical conduction of melanin.

Mostert AB, Powell BJ, Pratt FL, Hanson GR, Sarna T, Gentle IR, Meredith P.

Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8943-7. doi: 10.1073/pnas.1119948109. Epub 2012 May 21.

48.

Spectroscopic and catalytic characterization of a functional Fe(III)Fe(II) biomimetic for the active site of uteroferrin and protein cleavage.

Smith SJ, Peralta RA, Jovito R, Horn A Jr, Bortoluzzi AJ, Noble CJ, Hanson GR, Stranger R, Jayaratne V, Cavigliasso G, Gahan LR, Schenk G, Nascimento OR, Cavalett A, Bortolotto T, Razzera G, Terenzi H, Neves A, Riley MJ.

Inorg Chem. 2012 Feb 20;51(4):2065-78. doi: 10.1021/ic201711p. Epub 2012 Jan 30.

PMID:
22289382
49.

Cu(II) coordination chemistry of patellamide derivatives: possible biological functions of cyclic pseudopeptides.

Comba P, Dovalil N, Gahan LR, Haberhauer G, Hanson GR, Noble CJ, Seibold B, Vadivelu P.

Chemistry. 2012 Feb 27;18(9):2578-90. doi: 10.1002/chem.201101975. Epub 2012 Jan 20.

PMID:
22266951
50.

Response of limbic neurotensin systems to methamphetamine self-administration.

Hanson GR, Hoonakker AJ, Alburges ME, McFadden LM, Robson CM, Frankel PS.

Neuroscience. 2012 Feb 17;203:99-107. doi: 10.1016/j.neuroscience.2011.12.037. Epub 2012 Jan 2.

Supplemental Content

Loading ...
Support Center